Avida Biomed is a start-up life sciences company developing high-performance target enrichment workflows with unique capabilities for clinical researchers studying cancer using next-generation sequencing (NGS) methods. Agilent Agilent recently announced the acquisition of life sciences company Avida Biomed.
This article is transferred from: https://www.itjuzi.com/merger/9615
This site is only for collection, and the copyright belongs to the original author.